grant

Interplay between metabolic reprogramming and oncogenic signalling in the cellular response to chemotherapy [ 2018 - 2020 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1146642]

Brief description Chemotherapy resistance is a major barrier to the treatment of triple-negative breast cancer (TNBC). We seek to uncover an intimate link between cell metabolism and oncogenic signalling pathways in regulating the cellular response to chemotherapy. Our studies will identify a critical mechanism limiting the therapeutic efficacy of chemotherapy and investigate combination therapy strategies that could improve the treatment of TNBC.

Funding Amount $AUD 654,035.07

Funding Scheme Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857